Medicine & Healthcare Emergency medicine

Deepak Verma from Chulalongkorn University and his international team of researchers are exploring ways to enhance chitosan using techniques like adding photosensitizers, dendrimers, and chemical modifications. They also surveyed the use of chitosan nanoparticles for medical purposes, notably wound dressings.

The physiological mechanisms underlying severe burns are not well understood. Researchers at Osaka University used mass spectrometry to identify key blood proteins associated with burn mortality. Ultimately, three proteins (HBA1, TTR, SERPINF2) were very highly correlated with morality rates. Further research into these proteins and their pathways may lead to better drugs to treat people with life-threatening burns.

A group of researchers at Osaka University used a noninvasive method to evaluate Cerebrovascular Autoregulation (CVAR) in patients after out-of-hospital cardiac arrest. The mortality rate increased significantly with the duration of time that CVAR was undetectable. It has been suggested that CVAR, a function that is normally present in the normal state, may be impaired after cardiac resuscitation. However, the relationship between CVAR function and patient prognosis has been unclear. The research examined CVAR over time, using the moving Pearson correlation coefficient calculated from regional cerebral oxygen saturation and mean blood pressure data, and performed a survival analysis using the presence or absence of CVAR as a time-dependent covariate. The findings of this study may first be useful in predicting neuroprognosis after cardiac resumption and may help avoid early withdrawal of treatment in those who may recover. In addition, they suggest that treatment and management that maintains proper CVAR after cardiac resumption may improve patient prognosis, which may be applied to the management of post-cardiac arrest resuscitation based on cerebral circulation to optimize treatment for each individual patient.

Scientists developed a novel device that predicts whether an ICU patient taken off mechanical ventilation is likely to suffer from respiratory emergencies, helping critical care teams to provide immediate life-saving interventions.

Researchers led by Osaka University identified plasma proteins associated with critical pathogenesis in COVID-19. Using a novel blood proteomics method, the researchers evaluated two discovery cohorts and one validation cohort of patients with COVID-19 and healthy volunteers. Cell adhesion proteins WFDC2, GDF15, CHI3L1, and KRT19 were shown to be associated with disease severity in patients with COVID-19, and may serve as potential targets for therapies to treat COVID-19 infection.

Even a small temperature drop in the tropical climate of Singapore increases the risk of heart attack among people aged 65 and above, say researchers from Duke-NUS Medical School, Singapore’s National Environment Agency and collaborators.

Osaka University researchers used a large dataset of trauma patients in Japan to determine the characteristics and biomarkers most strongly associated with mortality risk by employing machine learning methods. This work may help improve the practice of emergency medicine.

Researchers have discovered in mice an additional use of globins as an intravenous drug that can delay liver fibrosis progression. Last year, the application of recombinant human cytoglobin (CYGB) as a protein therapeutic agent against liver damage and cirrhosis was published in Hepatology (Hepatology 2021,73:2527-2545) by Professor Norifumi Kawada’s research group. Here, they studied the antifibrotic properties of the globin family members hemoglobin (HB), myoglobin (MB), and neuroglobin (NGB) in comparison with CYGB. All globins demonstrated greater antioxidant capacity than glutathione in cell-free systems. Interestingly, all globins, except HB, could enter the cells and inhibit the collagen synthesis leading to a suppression of fibrosis development both in vitro and in vivo. The study was published in the journal Redox Biology.

Researchers from the Osaka City University Graduate School of Medicine have shown in patients with early-stage hepatocellular carcinoma who received cancer treatment that eliminating the hepatitis C virus with a direct-acting antiviral treatment reduces the risk of the liver cancer progression and increases overall patient survival.

Scientists are turning to genomics to better understand the epidemiology of malaria and to inform control and elimination interventions and strategies. In the Lake Victoria region of Kenya, malaria burden remains very high despite more than a decade of intense control activities. A team of researchers from Osaka City University, Nagasaki University, London School of Hygiene and Tropical Medicine, and Mount Kenya University generated whole Plasmodium falciparum genome sequences from the lake region. Their analyses revealed that malaria parasites from this region appear distinct from other parasites from East Africa, while frequencies of known drug resistance markers were similar to those in other East African parasite populations. Their findings will help to develop improved surveillance tools to determine parasite transmission routes and aid clinical disease management.

Researchers reveal through a systematic review of 158 articles detailing quality improvements in pediatric intensive care units mainly throughout North America and the U.K. that despite having a median score of 11.0 on the Quality Improvement Minimum Quality Criteria Set, only 17% of them were considered high quality by achieving a 14-16 score, and only 5% cited Standards for QUality Improvement Reporting Excellence (SQUIRE) guidelines for reporting quality improvement works.

A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first known agent to successfully target the virus and disturb its latency in tumour cells in this way.

The UK today confirmed that it will be the largest supporter of the international alliance to vaccinate children against deadly diseases, saving millions of lives.

An international team of researchers, affilated with UNIST has identified a new gene that causes drug resistance against Novartis’s breakthrough cancer drug, Gleevec (Active ingredient: imatinib).

A new model may help clinicians predict the possibility of death from severe dengue infection.